Shuttle Pharmaceuticals Holdings, Inc.
SHPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001757499
In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 4 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Shuttle Pharmaceuticals Holdings, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −1 vs. Q4 2025
- Shares held
- 158.9K
- +42.3K (+36.3%) vs. Q4 2025
- Total value
- $107.4K
- −$102.4K (−48.8%) vs. Q4 2025
- New holders
- 2
- 2 more added
- Sold out
- 3
- 1 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SHPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $338.2K |
| Q1 2026 | 8 | $107.4K |
| Q4 2025 | 9 | $209.9K |
| Q3 2025 | 7 | $512.7K |
| Q2 2025 | 5 | $16.9K |
| Q1 2025 | 8 | $87.5K |
| Q4 2024 | 6 | $306.1K |
| Q3 2024 | 4 | $39.2K |
| Q2 2024 | 6 | $34.6K |
| Q1 2024 | 7 | $26.8K |
| Q4 2023 | 7 | $61.5K |
| Q3 2023 | 5 | $158.3K |
| Q2 2023 | 2 | $290.7K |
| Q1 2023 | 3 | $49.2K |
| Q4 2022 | 9 | $264.6K |
| Q3 2022 | 11 | $2.32M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Shuttle Pharmaceuticals Holdings, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 68,993 | $46.8K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 46,217 | $31.4K | 0.00% | +31,773+220.0% | Added |
| Boothbay Fund Management, LLC | 20,360 | $13.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,380 | $8.00K | 0.00% | +12,380 | New |
| UBS Group AG | 5,670 | $3.85K | 0.00% | −6,277−52.5% | Reduced |
| Tower Research Capital LLC (TRC) | 4,641 | $3.15K | 0.00% | +3,829+471.6% | Added |
| Wall Street Access Asset Management, LLC | 600 | $407 | 0.00% | +600 | New |
| Morgan Stanley | 27 | $18 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |